Specifically, overexpression of FATP5 promotes both in vivo and in vitro progression of PCa and is deeply involved in PCa lipid metabolism, which is dependent on the interaction between TEAD4 and YAP1 in the Hippo signaling pathway. The gene discussed is SLC27A5; the disease is posterior cortical atrophy.